

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 6.26361927 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.19660886 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.19660886 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.93985694 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.93985694 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.93399148 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.93399148 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.93399148 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.93399148 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.93399148 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.93399148 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.91141377 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.71031682 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.57485140 |
| 15 | regulation of protein activation cascade (GO:2000257) | 5.51565792 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 5.42342403 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40243482 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.34031021 |
| 19 | negative regulation of cell killing (GO:0031342) | 5.34031021 |
| 20 | regulation of complement activation (GO:0030449) | 5.18607712 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.11121406 |
| 22 | detection of external biotic stimulus (GO:0098581) | 5.03296945 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 5.01722567 |
| 24 | urea cycle (GO:0000050) | 4.98832605 |
| 25 | urea metabolic process (GO:0019627) | 4.98832605 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.97117503 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.86385784 |
| 28 | protein carboxylation (GO:0018214) | 4.86385784 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.85298221 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.84316176 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.83051480 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.82457251 |
| 33 | detection of other organism (GO:0098543) | 4.80047301 |
| 34 | tryptophan catabolic process (GO:0006569) | 4.77242587 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 4.77242587 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 4.77242587 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.74835405 |
| 38 | kynurenine metabolic process (GO:0070189) | 4.73198038 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.69763544 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69522446 |
| 41 | microglial cell activation (GO:0001774) | 4.62555103 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.58102780 |
| 43 | cysteine metabolic process (GO:0006534) | 4.53613495 |
| 44 | cellular extravasation (GO:0045123) | 4.52972320 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 4.52263722 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.51860195 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.51860195 |
| 48 | tryptophan metabolic process (GO:0006568) | 4.48922586 |
| 49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.47349372 |
| 50 | low-density lipoprotein particle clearance (GO:0034383) | 4.45274703 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45254049 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42486787 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 4.38648505 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.31387052 |
| 55 | detection of biotic stimulus (GO:0009595) | 4.30017870 |
| 56 | valine metabolic process (GO:0006573) | 4.24259434 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21958866 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21925729 |
| 59 | detection of bacterium (GO:0016045) | 4.20454205 |
| 60 | bile acid metabolic process (GO:0008206) | 4.19405315 |
| 61 | lysine metabolic process (GO:0006553) | 4.17604162 |
| 62 | lysine catabolic process (GO:0006554) | 4.17604162 |
| 63 | macrophage activation (GO:0042116) | 4.17255821 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.15788036 |
| 65 | response to host immune response (GO:0052572) | 4.15788036 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 4.14036434 |
| 67 | serine family amino acid catabolic process (GO:0009071) | 4.11406964 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 4.11175456 |
| 69 | homocysteine metabolic process (GO:0050667) | 4.10683505 |
| 70 | negative regulation of complement activation (GO:0045916) | 4.10117877 |
| 71 | reverse cholesterol transport (GO:0043691) | 4.07389697 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 4.05630931 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05212596 |
| 74 | tyrosine metabolic process (GO:0006570) | 4.01990771 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 4.00821209 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 4.00821209 |
| 77 | macromolecular complex remodeling (GO:0034367) | 4.00821209 |
| 78 | response to peptidoglycan (GO:0032494) | 3.98444706 |
| 79 | regulation of sequestering of triglyceride (GO:0010889) | 3.97477535 |
| 80 | positive regulation of fatty acid oxidation (GO:0046321) | 3.96200983 |
| 81 | negative regulation of humoral immune response (GO:0002921) | 3.95206658 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 3.92409289 |
| 83 | triglyceride catabolic process (GO:0019433) | 3.92125547 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.91830739 |
| 85 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.90768055 |
| 86 | negative regulation of B cell mediated immunity (GO:0002713) | 3.90768055 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.90490559 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90096392 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 3.88364340 |
| 90 | aromatic amino acid family metabolic process (GO:0009072) | 3.86993710 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.86808302 |
| 92 | neutrophil mediated immunity (GO:0002446) | 3.86665177 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.85048961 |
| 94 | response to host (GO:0075136) | 3.84998295 |
| 95 | response to host defenses (GO:0052200) | 3.84998295 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.84998295 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.84759240 |
| 98 | complement activation (GO:0006956) | 3.84503457 |
| 99 | acute-phase response (GO:0006953) | 3.82872043 |
| 100 | regulation of cholesterol esterification (GO:0010872) | 3.82699194 |
| 101 | ethanol oxidation (GO:0006069) | 3.82192136 |
| 102 | phospholipid efflux (GO:0033700) | 3.81514487 |
| 103 | acylglycerol catabolic process (GO:0046464) | 3.81426152 |
| 104 | neutral lipid catabolic process (GO:0046461) | 3.81426152 |
| 105 | fatty acid oxidation (GO:0019395) | 3.81410239 |
| 106 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78670220 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.75247273 |
| 108 | negative regulation of interleukin-12 production (GO:0032695) | 3.74101583 |
| 109 | lipid oxidation (GO:0034440) | 3.74054470 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.73323056 |
| 111 | fatty acid transmembrane transport (GO:1902001) | 3.73228289 |
| 112 | response to interleukin-15 (GO:0070672) | 3.72788800 |
| 113 | cytolysis (GO:0019835) | 3.72747316 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.69301720 |
| 115 | fibrinolysis (GO:0042730) | 3.67411801 |
| 116 | coenzyme catabolic process (GO:0009109) | 3.66701036 |
| 117 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63749612 |
| 118 | fatty acid catabolic process (GO:0009062) | 3.62874326 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.62597450 |
| 120 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.60682877 |
| 121 | opsonization (GO:0008228) | 3.59676353 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 3.59602676 |
| 123 | biotin metabolic process (GO:0006768) | 3.59282965 |
| 124 | protein activation cascade (GO:0072376) | 3.58762264 |
| 125 | neutrophil activation (GO:0042119) | 3.58735517 |
| 126 | cellular ketone body metabolic process (GO:0046950) | 3.55194147 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.50782124 |
| 128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.48889557 |
| 129 | bile acid and bile salt transport (GO:0015721) | 3.48137728 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 3.47776930 |
| 131 | regulation of cholesterol homeostasis (GO:2000188) | 3.47712961 |
| 132 | cholesterol efflux (GO:0033344) | 3.41629457 |
| 133 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.41416997 |
| 134 | leukocyte aggregation (GO:0070486) | 3.41100496 |
| 135 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.40725965 |
| 136 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.40508632 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.39965998 |
| 138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.39965998 |
| 139 | short-chain fatty acid metabolic process (GO:0046459) | 3.39528460 |
| 140 | respiratory burst (GO:0045730) | 3.38620205 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 3.38156899 |
| 142 | negative regulation of sterol transport (GO:0032372) | 3.38156899 |
| 143 | cellular response to interleukin-15 (GO:0071350) | 3.37654721 |
| 144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37559478 |
| 145 | organic acid catabolic process (GO:0016054) | 3.37081134 |
| 146 | carboxylic acid catabolic process (GO:0046395) | 3.37081134 |
| 147 | cholesterol homeostasis (GO:0042632) | 3.34590222 |
| 148 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.34088217 |
| 149 | arginine metabolic process (GO:0006525) | 3.33896898 |
| 150 | regulation of plasminogen activation (GO:0010755) | 3.32089228 |
| 151 | cellular glucuronidation (GO:0052695) | 3.31679699 |
| 152 | regulation of triglyceride metabolic process (GO:0090207) | 3.31354971 |
| 153 | myeloid leukocyte mediated immunity (GO:0002444) | 3.30378648 |
| 154 | sterol homeostasis (GO:0055092) | 3.29681224 |
| 155 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.28996891 |
| 156 | plasma lipoprotein particle assembly (GO:0034377) | 3.28888846 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.27143149 |
| 158 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.23016467 |
| 159 | dendritic cell migration (GO:0036336) | 3.18430411 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18181321 |
| 161 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18181321 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 3.16227707 |
| 163 | negative regulation of T cell mediated immunity (GO:0002710) | 3.14502381 |
| 164 | granulocyte activation (GO:0036230) | 3.13265188 |
| 165 | germinal center formation (GO:0002467) | 3.03799734 |
| 166 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00288236 |
| 167 | immunoglobulin mediated immune response (GO:0016064) | 2.99958015 |
| 168 | negative regulation of adaptive immune response (GO:0002820) | 2.98906544 |
| 169 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97648103 |
| 170 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96476194 |
| 171 | B cell receptor signaling pathway (GO:0050853) | 2.91483321 |
| 172 | negative regulation of type 2 immune response (GO:0002829) | 2.90067209 |
| 173 | response to type I interferon (GO:0034340) | 2.88433532 |
| 174 | regulation of tolerance induction (GO:0002643) | 2.87673780 |
| 175 | cellular response to type I interferon (GO:0071357) | 2.86567151 |
| 176 | type I interferon signaling pathway (GO:0060337) | 2.86567151 |
| 177 | T-helper 1 type immune response (GO:0042088) | 2.82650938 |
| 178 | dendritic cell chemotaxis (GO:0002407) | 2.81359561 |
| 179 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81292822 |
| 180 | positive regulation of interferon-alpha production (GO:0032727) | 2.78321601 |
| 181 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.76176913 |
| 182 | positive regulation of tolerance induction (GO:0002645) | 2.75779954 |
| 183 | cellular response to epinephrine stimulus (GO:0071872) | 2.75372042 |
| 184 | regulation of mast cell degranulation (GO:0043304) | 2.74753728 |
| 185 | regulation of regulatory T cell differentiation (GO:0045589) | 2.73075070 |
| 186 | neutrophil chemotaxis (GO:0030593) | 2.71636969 |
| 187 | defense response to protozoan (GO:0042832) | 2.70596937 |
| 188 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70298955 |
| 189 | regulation of macrophage cytokine production (GO:0010935) | 2.67701709 |
| 190 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.67410137 |
| 191 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.64416365 |
| 192 | neutrophil migration (GO:1990266) | 2.64317029 |
| 193 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63862256 |
| 194 | regulation of necroptotic process (GO:0060544) | 2.63494999 |
| 195 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61508867 |
| 196 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60497561 |
| 197 | regulation of mast cell activation (GO:0033003) | 2.60064429 |
| 198 | negative regulation of interleukin-6 production (GO:0032715) | 2.59333947 |
| 199 | I-kappaB phosphorylation (GO:0007252) | 2.58893990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.96736654 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.72116571 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.03299939 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.04543134 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.65285227 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.38630499 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.47854006 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00402428 |
| 9 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.94569666 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90560006 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79457775 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65942854 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30032707 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.28997124 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.99634168 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.88835429 |
| 17 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.82272976 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71643790 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64374496 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62433815 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.57584799 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38803781 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25829662 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19625501 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18646053 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.01523809 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.99991952 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86216619 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85794875 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84393246 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82211112 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.79756367 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76657643 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73130099 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.65506870 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62356475 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59586144 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57649342 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57072947 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55459622 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50681197 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46574515 |
| 43 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44969264 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44513063 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41474599 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39143859 |
| 47 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36026317 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.33820569 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32802064 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31756234 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30763969 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29482342 |
| 53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27666171 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25834917 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24920701 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.24196674 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24099219 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23872808 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23468005 |
| 60 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20919923 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20693730 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17512609 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16691067 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14148545 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12063012 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11775275 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09267279 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08782902 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08519966 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08350495 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06225084 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05711035 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05710674 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04128590 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03976631 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03883222 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03353478 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03051790 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02951948 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01536594 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00890519 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00427871 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00061688 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99687354 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98160720 |
| 86 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.98123593 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97507782 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97111228 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97111228 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97074579 |
| 91 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95008768 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94401230 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94040764 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92687186 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91946297 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91677686 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91042720 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90377820 |
| 99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89586399 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88146688 |
| 101 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87647482 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87164340 |
| 103 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86826315 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86593313 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85866537 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83512291 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82948246 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82183106 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82056338 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81893820 |
| 111 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81282358 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80092653 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80092653 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80092475 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78791507 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78022296 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77881700 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76610679 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75726816 |
| 120 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73520891 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72913571 |
| 122 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71849870 |
| 123 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71608391 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68245076 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66377353 |
| 126 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.65577529 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63816900 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62696009 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61663466 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61107138 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60756518 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59670095 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.58641473 |
| 134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58598546 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58279573 |
| 136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.58011685 |
| 137 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57592252 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57509641 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56793693 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56792837 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56172381 |
| 142 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55777294 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55201458 |
| 144 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.54791322 |
| 145 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54107186 |
| 146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53679801 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52623498 |
| 148 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.51814749 |
| 149 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51694172 |
| 150 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.51664363 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.51185189 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50783262 |
| 153 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49463187 |
| 154 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.49443094 |
| 155 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.49146852 |
| 156 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.48614045 |
| 157 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48488824 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47621798 |
| 159 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.45954374 |
| 160 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.45285907 |
| 161 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.45266597 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44775395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.51588395 |
| 2 | MP0005360_urolithiasis | 6.10282493 |
| 3 | MP0005365_abnormal_bile_salt | 5.10743465 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.00128069 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89747691 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.73597725 |
| 7 | MP0005670_abnormal_white_adipose | 3.26401444 |
| 8 | MP0003303_peritoneal_inflammation | 3.09376901 |
| 9 | MP0003252_abnormal_bile_duct | 3.07371361 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 3.06342678 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.03714263 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.03252015 |
| 13 | MP0002419_abnormal_innate_immunity | 2.77828932 |
| 14 | MP0009785_altered_susceptibility_to | 2.54420825 |
| 15 | MP0003828_pulmonary_edema | 2.51334552 |
| 16 | MP0009840_abnormal_foam_cell | 2.50605198 |
| 17 | MP0005025_abnormal_response_to | 2.38797422 |
| 18 | MP0000685_abnormal_immune_system | 2.37792107 |
| 19 | MP0001800_abnormal_humoral_immune | 2.36796286 |
| 20 | MP0005332_abnormal_amino_acid | 2.32286833 |
| 21 | MP0005387_immune_system_phenotype | 2.31618414 |
| 22 | MP0001790_abnormal_immune_system | 2.31618414 |
| 23 | MP0004130_abnormal_muscle_cell | 2.31111994 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.25926793 |
| 25 | MP0005083_abnormal_biliary_tract | 2.25713806 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 2.21174997 |
| 27 | MP0005666_abnormal_adipose_tissue | 2.19768009 |
| 28 | MP0000609_abnormal_liver_physiology | 2.17300893 |
| 29 | MP0005000_abnormal_immune_tolerance | 2.13228564 |
| 30 | MP0003195_calcinosis | 2.10898148 |
| 31 | MP0002723_abnormal_immune_serum | 2.08765751 |
| 32 | MP0002132_abnormal_respiratory_system | 2.03666614 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.99511726 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.99229940 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.96164431 |
| 36 | MP0004381_abnormal_hair_follicle | 1.95110534 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.95010553 |
| 38 | MP0008260_abnormal_autophagy | 1.94860614 |
| 39 | MP0002254_reproductive_system_inflammat | 1.92776637 |
| 40 | MP0001819_abnormal_immune_cell | 1.92696768 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.90449600 |
| 42 | MP0006082_CNS_inflammation | 1.90039058 |
| 43 | MP0005671_abnormal_response_to | 1.87031454 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.86515754 |
| 45 | MP0002405_respiratory_system_inflammati | 1.86142776 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.77822773 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.75111949 |
| 48 | MP0008004_abnormal_stomach_pH | 1.73234239 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.70945172 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.67082133 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.66291554 |
| 52 | MP0002971_abnormal_brown_adipose | 1.63765985 |
| 53 | MP0001958_emphysema | 1.61571211 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.61564106 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.57448982 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.55063477 |
| 57 | MP0004947_skin_inflammation | 1.53807541 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.52512514 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.48999872 |
| 60 | MP0005275_abnormal_skin_tensile | 1.47183764 |
| 61 | MP0001851_eye_inflammation | 1.46521132 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46399489 |
| 63 | MP0003186_abnormal_redox_activity | 1.42792752 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.41178871 |
| 65 | MP0004484_altered_response_of | 1.40377625 |
| 66 | MP0001661_extended_life_span | 1.38974753 |
| 67 | MP0000716_abnormal_immune_system | 1.38837763 |
| 68 | MP0001764_abnormal_homeostasis | 1.38799109 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.36000287 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.35948304 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.35326159 |
| 72 | MP0005334_abnormal_fat_pad | 1.34421865 |
| 73 | MP0003724_increased_susceptibility_to | 1.32745809 |
| 74 | MP0003866_abnormal_defecation | 1.30789145 |
| 75 | MP0003045_fibrosis | 1.30634750 |
| 76 | MP0002398_abnormal_bone_marrow | 1.27768261 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.23666413 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.21422139 |
| 79 | MP0009115_abnormal_fat_cell | 1.21400990 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.19521701 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.19521701 |
| 82 | MP0003868_abnormal_feces_composition | 1.18572836 |
| 83 | MP0000858_altered_metastatic_potential | 1.15729858 |
| 84 | MP0009763_increased_sensitivity_to | 1.14665767 |
| 85 | MP0009278_abnormal_bone_marrow | 1.13264089 |
| 86 | MP0009764_decreased_sensitivity_to | 1.12549878 |
| 87 | MP0002722_abnormal_immune_system | 1.11783890 |
| 88 | MP0005388_respiratory_system_phenotype | 1.11237203 |
| 89 | MP0002133_abnormal_respiratory_system | 1.11237203 |
| 90 | MP0000689_abnormal_spleen_morphology | 1.10556201 |
| 91 | MP0000598_abnormal_liver_morphology | 1.09262053 |
| 92 | MP0003011_delayed_dark_adaptation | 1.08316936 |
| 93 | MP0003183_abnormal_peptide_metabolism | 1.08103683 |
| 94 | MP0003172_abnormal_lysosome_physiology | 1.05922083 |
| 95 | MP0005647_abnormal_sex_gland | 1.05082987 |
| 96 | MP0005310_abnormal_salivary_gland | 1.04396417 |
| 97 | MP0003690_abnormal_glial_cell | 1.04390298 |
| 98 | MP0004272_abnormal_basement_membrane | 1.01504038 |
| 99 | MP0002332_abnormal_exercise_endurance | 1.01461977 |
| 100 | MP0000604_amyloidosis | 1.01285258 |
| 101 | MP0005535_abnormal_body_temperature | 1.01256312 |
| 102 | MP0002429_abnormal_blood_cell | 1.00664894 |
| 103 | MP0000013_abnormal_adipose_tissue | 1.00029073 |
| 104 | MP0005166_decreased_susceptibility_to | 0.99175852 |
| 105 | MP0002060_abnormal_skin_morphology | 0.96314370 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.95533585 |
| 107 | MP0009697_abnormal_copulation | 0.94126238 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.93374764 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.93050803 |
| 110 | MP0002006_tumorigenesis | 0.92100565 |
| 111 | MP0002970_abnormal_white_adipose | 0.91900613 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.89669754 |
| 113 | MP0001881_abnormal_mammary_gland | 0.88750780 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.88019442 |
| 115 | MP0005448_abnormal_energy_balance | 0.87528390 |
| 116 | MP0005390_skeleton_phenotype | 0.87329062 |
| 117 | MP0008469_abnormal_protein_level | 0.86287426 |
| 118 | MP0002796_impaired_skin_barrier | 0.86138147 |
| 119 | MP0003448_altered_tumor_morphology | 0.83407949 |
| 120 | MP0003091_abnormal_cell_migration | 0.81241150 |
| 121 | MP0005164_abnormal_response_to | 0.80753805 |
| 122 | MP0005023_abnormal_wound_healing | 0.80718803 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.76561459 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.76211754 |
| 125 | MP0001756_abnormal_urination | 0.76192625 |
| 126 | MP0005451_abnormal_body_composition | 0.75000539 |
| 127 | MP0003959_abnormal_lean_body | 0.74682510 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.74076688 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.74020381 |
| 130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73426659 |
| 131 | MP0004510_myositis | 0.71318710 |
| 132 | MP0003795_abnormal_bone_structure | 0.69484538 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.68663750 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.67861306 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.66544266 |
| 136 | MP0003075_altered_response_to | 0.65680702 |
| 137 | MP0004808_abnormal_hematopoietic_stem | 0.63799951 |
| 138 | MP0000015_abnormal_ear_pigmentation | 0.63591274 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.62546414 |
| 140 | MP0002933_joint_inflammation | 0.62430302 |
| 141 | MP0005636_abnormal_mineral_homeostasis | 0.62037140 |
| 142 | MP0003279_aneurysm | 0.61969197 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.61709237 |
| 144 | MP0002168_other_aberrant_phenotype | 0.61577246 |
| 145 | MP0002009_preneoplasia | 0.61092996 |
| 146 | MP0002295_abnormal_pulmonary_circulatio | 0.59545772 |
| 147 | MP0010234_abnormal_vibrissa_follicle | 0.58620696 |
| 148 | MP0000343_altered_response_to | 0.58361356 |
| 149 | MP0000249_abnormal_blood_vessel | 0.57893101 |
| 150 | MP0003436_decreased_susceptibility_to | 0.57502477 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.56112937 |
| 152 | MP0000427_abnormal_hair_cycle | 0.55894948 |
| 153 | MP0005266_abnormal_metabolism | 0.53085925 |
| 154 | MP0004883_abnormal_blood_vessel | 0.52720008 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.52571811 |
| 156 | MP0005220_abnormal_exocrine_pancreas | 0.52154668 |
| 157 | MP0003300_gastrointestinal_ulcer | 0.52051168 |
| 158 | MP0006138_congestive_heart_failure | 0.51406440 |
| 159 | MP0000579_abnormal_nail_morphology | 0.51252612 |
| 160 | MP0002136_abnormal_kidney_physiology | 0.51093584 |
| 161 | MP0001853_heart_inflammation | 0.50064265 |
| 162 | MP0005452_abnormal_adipose_tissue | 0.50063011 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.49888278 |
| 164 | MP0008775_abnormal_heart_ventricle | 0.49739594 |
| 165 | MP0001533_abnormal_skeleton_physiology | 0.48336792 |
| 166 | MP0002166_altered_tumor_susceptibility | 0.48268012 |
| 167 | MP0001243_abnormal_dermal_layer | 0.46824733 |
| 168 | MP0004782_abnormal_surfactant_physiolog | 0.46785929 |
| 169 | MP0003453_abnormal_keratinocyte_physiol | 0.45751891 |
| 170 | MP0003953_abnormal_hormone_level | 0.45381900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.50752928 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.45699025 |
| 3 | Complement deficiency (HP:0004431) | 6.41737772 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.80281264 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.79500990 |
| 6 | Xanthomatosis (HP:0000991) | 5.75492154 |
| 7 | Orchitis (HP:0100796) | 5.72012523 |
| 8 | Myositis (HP:0100614) | 5.69699530 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 5.42079678 |
| 10 | Optic neuritis (HP:0100653) | 5.42079678 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.36102791 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 5.34305134 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 5.28067978 |
| 14 | Recurrent abscess formation (HP:0002722) | 5.25274799 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.19312500 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.82499739 |
| 17 | Abnormality of complement system (HP:0005339) | 4.70372550 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.58862623 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.58851275 |
| 20 | Epidermoid cyst (HP:0200040) | 4.48317320 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 4.41709821 |
| 22 | Hypolipoproteinemia (HP:0010981) | 4.40209009 |
| 23 | Hyperammonemia (HP:0001987) | 4.30953850 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26455417 |
| 25 | Hyperglycinuria (HP:0003108) | 4.24020455 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 4.10883218 |
| 27 | Ketosis (HP:0001946) | 4.10437933 |
| 28 | Keratoconjunctivitis (HP:0001096) | 4.09639875 |
| 29 | Hypoglycemic coma (HP:0001325) | 4.06799170 |
| 30 | Hyperglycinemia (HP:0002154) | 4.04418386 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04163220 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 4.02033279 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02033279 |
| 34 | Joint hemorrhage (HP:0005261) | 3.98924128 |
| 35 | Abnormality of macrophages (HP:0004311) | 3.98413978 |
| 36 | Stomatitis (HP:0010280) | 3.89627355 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85719547 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.80550505 |
| 39 | Gingivitis (HP:0000230) | 3.72864529 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.63990533 |
| 41 | Increased IgE level (HP:0003212) | 3.55383693 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54677002 |
| 43 | Spontaneous abortion (HP:0005268) | 3.53339518 |
| 44 | Myocardial infarction (HP:0001658) | 3.52058247 |
| 45 | Recurrent skin infections (HP:0001581) | 3.49354144 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42775986 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 3.39768099 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39515624 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 3.37725024 |
| 50 | Hypercholesterolemia (HP:0003124) | 3.36627910 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 3.34314555 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.27396291 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.27315730 |
| 54 | Fat malabsorption (HP:0002630) | 3.26514328 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26199575 |
| 56 | Ketoacidosis (HP:0001993) | 3.19676418 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 3.16400600 |
| 58 | Arterial thrombosis (HP:0004420) | 3.15275048 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.11852049 |
| 60 | Hemoptysis (HP:0002105) | 3.08223861 |
| 61 | Meningitis (HP:0001287) | 3.07781912 |
| 62 | Encephalitis (HP:0002383) | 3.05869579 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02315280 |
| 64 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02315280 |
| 65 | Skin nodule (HP:0200036) | 3.02095327 |
| 66 | Abnormality of T cell number (HP:0011839) | 3.01161009 |
| 67 | T lymphocytopenia (HP:0005403) | 3.00823531 |
| 68 | Urticaria (HP:0001025) | 2.99772176 |
| 69 | Amyloidosis (HP:0011034) | 2.99428667 |
| 70 | Vasculitis (HP:0002633) | 2.98632084 |
| 71 | Hypertriglyceridemia (HP:0002155) | 2.93189649 |
| 72 | Chest pain (HP:0100749) | 2.92790582 |
| 73 | Obstructive lung disease (HP:0006536) | 2.92375058 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92375058 |
| 75 | Pulmonary embolism (HP:0002204) | 2.74380774 |
| 76 | Episodic fever (HP:0001954) | 2.74246784 |
| 77 | Oligomenorrhea (HP:0000876) | 2.73579927 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.72645691 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.68768364 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.67328652 |
| 81 | Gangrene (HP:0100758) | 2.66471546 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.65577289 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60988565 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.60184139 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58838484 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.58838484 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.58187229 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.58187229 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57933786 |
| 90 | Leukocytosis (HP:0001974) | 2.57533615 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.56954726 |
| 92 | Anorexia (HP:0002039) | 2.56869416 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54950855 |
| 94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53433078 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.49265947 |
| 96 | Hypochromic anemia (HP:0001931) | 2.47500489 |
| 97 | Acanthosis nigricans (HP:0000956) | 2.47003072 |
| 98 | Hyperbilirubinemia (HP:0002904) | 2.46737427 |
| 99 | Steatorrhea (HP:0002570) | 2.44247995 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.42822440 |
| 101 | Cellulitis (HP:0100658) | 2.41988737 |
| 102 | Gingival bleeding (HP:0000225) | 2.38694698 |
| 103 | Glomerulonephritis (HP:0000099) | 2.36229838 |
| 104 | Muscle fiber splitting (HP:0003555) | 2.35904134 |
| 105 | Mitral stenosis (HP:0001718) | 2.35898421 |
| 106 | Abnormality of the peritoneum (HP:0002585) | 2.35693388 |
| 107 | Epistaxis (HP:0000421) | 2.34937196 |
| 108 | Metabolic acidosis (HP:0001942) | 2.34207475 |
| 109 | Subacute progressive viral hepatitis (HP:0006572) | 2.31521963 |
| 110 | Papilledema (HP:0001085) | 2.30965066 |
| 111 | Esophageal varix (HP:0002040) | 2.30543102 |
| 112 | Abnormality of the endocardium (HP:0004306) | 2.29940134 |
| 113 | Pancreatitis (HP:0001733) | 2.28982060 |
| 114 | Lethargy (HP:0001254) | 2.28667306 |
| 115 | Hypoglycemic seizures (HP:0002173) | 2.28095058 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.27552170 |
| 117 | Recurrent bronchitis (HP:0002837) | 2.27503670 |
| 118 | Difficulty running (HP:0009046) | 2.27354209 |
| 119 | Alveolar cell carcinoma (HP:0006519) | 2.25884225 |
| 120 | Abnormality of the pleura (HP:0002103) | 2.24270933 |
| 121 | Osteomyelitis (HP:0002754) | 2.22523038 |
| 122 | Spastic diplegia (HP:0001264) | 2.22090257 |
| 123 | Metaphyseal cupping (HP:0003021) | 2.18044476 |
| 124 | Eosinophilia (HP:0001880) | 2.17443322 |
| 125 | Hyperglycemia (HP:0003074) | 2.17172944 |
| 126 | Abnormality of T cells (HP:0002843) | 2.16447504 |
| 127 | Granulocytopenia (HP:0001913) | 2.13979912 |
| 128 | Cholelithiasis (HP:0001081) | 2.12634386 |
| 129 | Abnormal gallbladder morphology (HP:0012437) | 2.11706367 |
| 130 | Myoglobinuria (HP:0002913) | 2.09429516 |
| 131 | Facial diplegia (HP:0001349) | 2.09126594 |
| 132 | Vascular calcification (HP:0004934) | 2.08763399 |
| 133 | Microcytic anemia (HP:0001935) | 2.08623149 |
| 134 | Cardiovascular calcification (HP:0011915) | 2.08545307 |
| 135 | Inflammation of the large intestine (HP:0002037) | 2.08252751 |
| 136 | Thrombophlebitis (HP:0004418) | 2.07209886 |
| 137 | Keratitis (HP:0000491) | 2.06190074 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 2.05852335 |
| 139 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05852335 |
| 140 | Nephritis (HP:0000123) | 2.05774454 |
| 141 | Nausea (HP:0002018) | 2.05300246 |
| 142 | Vertigo (HP:0002321) | 2.05201611 |
| 143 | Cerebral edema (HP:0002181) | 2.04884987 |
| 144 | Abnormality of the fingertips (HP:0001211) | 2.04168808 |
| 145 | Acne (HP:0001061) | 2.04165175 |
| 146 | Hypochromic microcytic anemia (HP:0004840) | 2.02458717 |
| 147 | Pigmentary retinal degeneration (HP:0001146) | 2.01530913 |
| 148 | Right ventricular cardiomyopathy (HP:0011663) | 2.01475238 |
| 149 | Pustule (HP:0200039) | 1.99454756 |
| 150 | Hypergammaglobulinemia (HP:0010702) | 1.99237051 |
| 151 | Neonatal onset (HP:0003623) | 1.98910313 |
| 152 | Ventricular fibrillation (HP:0001663) | 1.97653471 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.96236306 |
| 154 | Vomiting (HP:0002013) | 1.95806417 |
| 155 | Brushfield spots (HP:0001088) | 1.95567410 |
| 156 | Acute hepatic failure (HP:0006554) | 1.93693748 |
| 157 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91319569 |
| 158 | Slow saccadic eye movements (HP:0000514) | 1.91011381 |
| 159 | Peritonitis (HP:0002586) | 1.90241483 |
| 160 | Decreased circulating renin level (HP:0003351) | 1.89946354 |
| 161 | Nasal polyposis (HP:0100582) | 1.89354170 |
| 162 | Abnormality of the pericardium (HP:0001697) | 1.89043219 |
| 163 | Hyporeflexia of lower limbs (HP:0002600) | 1.87878455 |
| 164 | Gastrointestinal inflammation (HP:0004386) | 1.86638041 |
| 165 | Late onset (HP:0003584) | 1.85185724 |
| 166 | Toxemia of pregnancy (HP:0100603) | 1.83633557 |
| 167 | Irritability (HP:0000737) | 1.83096549 |
| 168 | Insulin resistance (HP:0000855) | 1.82360810 |
| 169 | Cheilitis (HP:0100825) | 1.82237781 |
| 170 | Recurrent viral infections (HP:0004429) | 1.81938410 |
| 171 | Gout (HP:0001997) | 1.81789169 |
| 172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80871276 |
| 173 | Sensorimotor neuropathy (HP:0007141) | 1.79142184 |
| 174 | Sepsis (HP:0100806) | 1.78630864 |
| 175 | Stomach cancer (HP:0012126) | 1.78199768 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.78164127 |
| 177 | Chronic otitis media (HP:0000389) | 1.77963723 |
| 178 | Ectopia lentis (HP:0001083) | 1.76520795 |
| 179 | Glomerulopathy (HP:0100820) | 1.76053077 |
| 180 | Abnormality of the nasal mucosa (HP:0000433) | 1.75781645 |
| 181 | Skin ulcer (HP:0200042) | 1.74855246 |
| 182 | Abnormality of eosinophils (HP:0001879) | 1.74143277 |
| 183 | Abnormal gallbladder physiology (HP:0012438) | 1.73904630 |
| 184 | Cholecystitis (HP:0001082) | 1.73904630 |
| 185 | Bronchitis (HP:0012387) | 1.73719595 |
| 186 | Aortic aneurysm (HP:0004942) | 1.73560145 |
| 187 | Hematochezia (HP:0002573) | 1.73457337 |
| 188 | Stroke (HP:0001297) | 1.73253367 |
| 189 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73005719 |
| 190 | Acanthocytosis (HP:0001927) | 1.72435392 |
| 191 | Elevated hepatic transaminases (HP:0002910) | 1.68461101 |
| 192 | Polycythemia (HP:0001901) | 1.68446456 |
| 193 | Malnutrition (HP:0004395) | 1.67926265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.17510425 |
| 2 | ERN1 | 4.90231240 |
| 3 | SIK1 | 4.30806666 |
| 4 | RIPK4 | 3.95709972 |
| 5 | FGFR4 | 3.77609791 |
| 6 | TRIB3 | 3.40689708 |
| 7 | BLK | 3.15689874 |
| 8 | CAMK1D | 2.90454959 |
| 9 | IRAK4 | 2.81100802 |
| 10 | MST1R | 2.36678226 |
| 11 | INSRR | 2.31384662 |
| 12 | FRK | 1.98463303 |
| 13 | FES | 1.97159841 |
| 14 | EPHA3 | 1.94578297 |
| 15 | ERBB4 | 1.92511030 |
| 16 | CAMK1G | 1.92239671 |
| 17 | MAP4K1 | 1.89948647 |
| 18 | LATS1 | 1.89687947 |
| 19 | ZAP70 | 1.85289718 |
| 20 | RIPK1 | 1.78420652 |
| 21 | EPHB1 | 1.74914046 |
| 22 | PDGFRA | 1.63788456 |
| 23 | FGFR2 | 1.59011561 |
| 24 | FGFR3 | 1.57038516 |
| 25 | YES1 | 1.54188430 |
| 26 | TXK | 1.52565428 |
| 27 | TNK2 | 1.51648396 |
| 28 | NEK9 | 1.50321611 |
| 29 | PKN2 | 1.50216105 |
| 30 | HCK | 1.48410965 |
| 31 | TYK2 | 1.46189619 |
| 32 | AKT3 | 1.44799020 |
| 33 | PRKAA2 | 1.42550419 |
| 34 | MYLK | 1.38863816 |
| 35 | MAPK11 | 1.37545898 |
| 36 | PTK6 | 1.36555423 |
| 37 | BTK | 1.35679697 |
| 38 | JAK1 | 1.35312162 |
| 39 | TIE1 | 1.33906019 |
| 40 | TAOK3 | 1.30249513 |
| 41 | PIK3CG | 1.29196965 |
| 42 | TAOK1 | 1.28431108 |
| 43 | FGR | 1.27778996 |
| 44 | TGFBR2 | 1.27377722 |
| 45 | FLT3 | 1.24704918 |
| 46 | JAK2 | 1.23424548 |
| 47 | PDK4 | 1.20575957 |
| 48 | PDK3 | 1.20575957 |
| 49 | MET | 1.20106898 |
| 50 | SYK | 1.19726995 |
| 51 | KSR2 | 1.19187394 |
| 52 | MAP2K4 | 1.18573175 |
| 53 | EPHB2 | 1.15617923 |
| 54 | ABL2 | 1.10678012 |
| 55 | MARK2 | 1.10222344 |
| 56 | TTN | 1.08854019 |
| 57 | LYN | 1.06859379 |
| 58 | MAP3K3 | 1.06618720 |
| 59 | FER | 1.04758233 |
| 60 | MAP3K13 | 1.04520407 |
| 61 | KDR | 1.04146480 |
| 62 | SGK2 | 1.03056337 |
| 63 | PTK2B | 1.02324390 |
| 64 | MATK | 0.98251836 |
| 65 | IRAK2 | 0.97378502 |
| 66 | DAPK2 | 0.97325994 |
| 67 | DDR2 | 0.97228255 |
| 68 | WNK1 | 0.96833842 |
| 69 | CDK6 | 0.95817339 |
| 70 | LRRK2 | 0.95618688 |
| 71 | PIK3CA | 0.92985885 |
| 72 | BMPR2 | 0.91954167 |
| 73 | MAP2K3 | 0.91456931 |
| 74 | STK38 | 0.85954833 |
| 75 | KIT | 0.85068269 |
| 76 | MAP2K1 | 0.83763680 |
| 77 | PRPF4B | 0.82903312 |
| 78 | LCK | 0.82785427 |
| 79 | MAP3K7 | 0.81654132 |
| 80 | OXSR1 | 0.80667480 |
| 81 | TEC | 0.79115812 |
| 82 | PDK2 | 0.78734348 |
| 83 | ITK | 0.78579559 |
| 84 | LMTK2 | 0.77003966 |
| 85 | MARK3 | 0.76127206 |
| 86 | STK10 | 0.74174152 |
| 87 | STK11 | 0.73575693 |
| 88 | MAP3K11 | 0.73458052 |
| 89 | MAP3K5 | 0.73214272 |
| 90 | TBK1 | 0.71819753 |
| 91 | ACVR1B | 0.70652672 |
| 92 | GSK3A | 0.68848602 |
| 93 | PRKAA1 | 0.68814855 |
| 94 | SGK223 | 0.64247544 |
| 95 | SGK494 | 0.64247544 |
| 96 | CDC42BPA | 0.63829945 |
| 97 | RET | 0.63232505 |
| 98 | ERBB2 | 0.62419846 |
| 99 | MAPK4 | 0.62172640 |
| 100 | MAPK12 | 0.62016673 |
| 101 | IRAK1 | 0.61338724 |
| 102 | CAMKK2 | 0.60996706 |
| 103 | MAP2K6 | 0.60463729 |
| 104 | PRKACG | 0.60373231 |
| 105 | CSK | 0.60347726 |
| 106 | RAF1 | 0.60048495 |
| 107 | HIPK2 | 0.60004063 |
| 108 | TRPM7 | 0.59425757 |
| 109 | NLK | 0.57505363 |
| 110 | CDK9 | 0.55287782 |
| 111 | MAP3K10 | 0.55067013 |
| 112 | PDPK1 | 0.53770612 |
| 113 | PDGFRB | 0.53740064 |
| 114 | IGF1R | 0.53661173 |
| 115 | MAP3K14 | 0.52953485 |
| 116 | PINK1 | 0.52736904 |
| 117 | MTOR | 0.52052354 |
| 118 | PRKD2 | 0.51244555 |
| 119 | STK38L | 0.50933000 |
| 120 | PTK2 | 0.50667560 |
| 121 | JAK3 | 0.49712317 |
| 122 | FYN | 0.49178779 |
| 123 | LATS2 | 0.49166563 |
| 124 | ADRBK1 | 0.47532515 |
| 125 | NEK6 | 0.47490248 |
| 126 | IKBKB | 0.47169984 |
| 127 | MAP3K6 | 0.45367458 |
| 128 | PAK3 | 0.45194995 |
| 129 | MELK | 0.43401582 |
| 130 | IRAK3 | 0.42739200 |
| 131 | PAK2 | 0.41608821 |
| 132 | CAMK2G | 0.40578346 |
| 133 | PRKCZ | 0.40015228 |
| 134 | IKBKE | 0.39513130 |
| 135 | PRKD1 | 0.39023291 |
| 136 | OBSCN | 0.38879352 |
| 137 | SGK3 | 0.36323190 |
| 138 | STK3 | 0.35665311 |
| 139 | FGFR1 | 0.34230244 |
| 140 | BMX | 0.33752863 |
| 141 | PRKCH | 0.32299625 |
| 142 | MAP3K1 | 0.32204052 |
| 143 | GRK6 | 0.31275219 |
| 144 | DYRK1B | 0.31023321 |
| 145 | CSF1R | 0.30836164 |
| 146 | MAPK7 | 0.30374056 |
| 147 | MAP3K2 | 0.29609423 |
| 148 | ABL1 | 0.28481036 |
| 149 | INSR | 0.28329637 |
| 150 | PHKG1 | 0.27307543 |
| 151 | PHKG2 | 0.27307543 |
| 152 | CDK4 | 0.26936159 |
| 153 | PDK1 | 0.25555666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05980418 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53688464 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94403209 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93253005 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90843657 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.77523922 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77093366 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74923062 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71102172 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65623330 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.60546673 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.58986592 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55721512 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47051053 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37300475 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23816188 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23665700 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14763894 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09262820 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.06619400 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.97352913 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96812692 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90274071 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89504164 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88091064 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84699593 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83703147 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79670463 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79630305 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77736860 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76366720 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72575949 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70345062 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.67811963 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67579898 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64903409 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61381134 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59131278 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57919150 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.57502873 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53899566 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53323788 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.51295034 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50756780 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48024089 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44992459 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.44488031 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43566600 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42774776 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41894789 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39461980 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39300207 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.37821422 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.37371912 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36780522 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35881632 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.33970683 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31909479 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.31000331 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29683802 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28972026 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28917357 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28536892 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28506822 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 1.28434248 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 1.26555737 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25544562 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25497848 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25115004 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22560588 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22483879 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21817960 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19921342 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19864003 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 1.19643395 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.16351471 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09958630 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08227349 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07658916 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06825815 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03999752 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.03464917 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01473606 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00428501 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99431019 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99295068 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99253092 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98416366 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97188770 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.96567093 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94916547 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93871428 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90282113 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89235712 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88409433 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88287477 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87957224 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85543833 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.81898094 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79793060 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79209616 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79031557 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.76339159 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75375775 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74644946 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74578356 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74380374 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74010308 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72996869 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72921662 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71553091 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70018269 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68400111 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67812052 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67676735 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66030694 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65874612 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65114740 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65101551 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64765806 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64252735 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63876455 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63862395 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62487608 |
| 125 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62071850 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.62029968 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61633057 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.61298558 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.61024619 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60943891 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60553892 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59875565 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.58400365 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55810905 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55057381 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52375256 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49916829 |
| 138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49696077 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.49466795 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48964959 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.48384210 |
| 142 | Asthma_Homo sapiens_hsa05310 | 0.48264615 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47982397 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46641356 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45486309 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40954652 |
| 147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40000008 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35402382 |
| 149 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32516276 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31335882 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24536701 |
| 152 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21755051 |
| 153 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21662078 |
| 154 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21283993 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20282439 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19656399 |
| 157 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18245596 |
| 158 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14325044 |
| 159 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14285136 |
| 160 | Amoebiasis_Homo sapiens_hsa05146 | 0.11303109 |
| 161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08261436 |
| 162 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08195051 |
| 163 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01359351 |
| 164 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1415335 |
| 165 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1253887 |
| 166 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1146012 |
| 167 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1139577 |
| 168 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0967051 |
| 169 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0861480 |
| 170 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0805795 |
| 171 | Focal adhesion_Homo sapiens_hsa04510 | -0.0706354 |
| 172 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0636278 |
| 173 | Malaria_Homo sapiens_hsa05144 | -0.0631736 |
| 174 | Pertussis_Homo sapiens_hsa05133 | -0.0552668 |
| 175 | Hepatitis C_Homo sapiens_hsa05160 | -0.0335560 |
| 176 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0329341 |
| 177 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0304714 |

